Erasca, Inc. (ERAS)
NASDAQ: ERAS · Real-Time Price · USD
13.46
-0.15 (-1.10%)
At close: Feb 25, 2026, 4:00 PM EST
13.59
+0.13 (0.97%)
After-hours: Feb 25, 2026, 7:38 PM EST
Erasca Market Cap
Erasca has a market cap or net worth of $4.17 billion as of February 25, 2026. Its market cap has increased by 826.96% in one year.
Market Cap
4.17B
Enterprise Value
3.85B
1-Year Change
826.96%
Ranking
Category
Stock Price
$13.46
Market Cap Chart
Since the IPO on July 16, 2021, Erasca's market cap has increased from $1.86B to $4.17B, an increase of 124.24%. That is a compound annual growth rate of 19.13%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 24, 2026 | 4.21B | 299.23% |
| Dec 31, 2025 | 1.06B | 48.72% |
| Dec 31, 2024 | 709.65M | 121.27% |
| Dec 29, 2023 | 320.72M | -50.41% |
| Dec 30, 2022 | 646.73M | -65.76% |
| Dec 31, 2021 | 1.89B | 1.66% |
| Jul 16, 2021 | 1.86B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| TG Therapeutics | 4.32B |
| Terns Pharmaceuticals | 4.27B |
| NewAmsterdam Pharma Company | 4.09B |
| ACADIA Pharmaceuticals | 4.06B |
| ADMA Biologics | 3.83B |
| Arcellx | 3.71B |
| Corcept Therapeutics | 3.66B |
| Ligand Pharmaceuticals | 3.62B |